117 related articles for article (PubMed ID: 2411699)
1. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
Falk JA; Lewis WH; Letarte M
Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
5. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
Letarte M; Addis J; Iturbe S; Petsche D
Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
[TBL] [Abstract][Full Text] [Related]
6. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
Radka SF; Machamer CE; Cresswell P
Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
[TBL] [Abstract][Full Text] [Related]
7. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
DeMars R; Chang CC; Rudersdorf RA
Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
[TBL] [Abstract][Full Text] [Related]
8. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
9. Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.
Johnson JP; Wank R
J Exp Med; 1984 Nov; 160(5):1350-9. PubMed ID: 6208309
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
[TBL] [Abstract][Full Text] [Related]
12. Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.
Lee SH; Gregersen PK; Shen HH; Nunez-Roldan A; Silver J; Winchester RJ
Rheumatol Int; 1984; 4 Suppl():17-23. PubMed ID: 6085817
[TBL] [Abstract][Full Text] [Related]
13. Molecular localization of human class II MT2 and MT3 determinants.
Hurley CK; Giles RC; Nunez G; DeMars R; Nadler L; Winchester R; Stastny P; Capra JD
J Exp Med; 1984 Aug; 160(2):472-93. PubMed ID: 6206179
[TBL] [Abstract][Full Text] [Related]
14. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
Johnson JP; Wank R
Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
[TBL] [Abstract][Full Text] [Related]
15. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
Sorrentino R; Lillie J; Strominger JL
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
[TBL] [Abstract][Full Text] [Related]
17. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.
Goyert SM; Silver J
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5719-23. PubMed ID: 6193521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
